About Hubei Honch Pharmaceutical Co., Ltd - Pharmaceutical Raw Material & Intermediates Supplier in China

Located in Hubei province, China, Hubei Honch Pharmaceutical Co., Ltd currently lists five active products in its catalogue. The product set includes four vinblastine‑type alkaloids - Vinorelbine tartrate, Vinorelbine base, Vinblastine sulfate, and Paclitaxel - as well as the taxane Docetaxel. All items fall under the supplier’s stated top categories of Pharmaceutical Raw Material & Intermediates, Industrial Chemicals, and Laboratory Chemicals, and are presented without additional branding or client claims. The catalogue does not provide HS‑code designations, so the listing is limited to the product names and their chemical class. The supplier is classified as an imported tier with a harbor trust rating, indicating a moderate level of verification within the platform’s trust framework.

The five listed compounds are widely used as cytotoxic agents in oncology research and formulation. Vinorelbine and Vinblastine derivatives are alkaloid‑based mitotic inhibitors, while Docetaxel and Paclitaxel belong to the taxane family. Buyers typically request these materials in high‑purity forms (≥98 % by HPLC) for pre‑clinical studies or as intermediates for further synthesis. Because the supplier’s catalogue does not mention specific grades or certifications, purchasers must verify compliance with relevant pharmacopeial standards such as USP, EP, or JP before procurement.

Product Range and Specialties of Hubei Honch Pharmaceutical Co., Ltd

The catalogue focuses on five anticancer agents: Vinorelbine tartrate, Vinorelbine base, Vinblastine sulfate, Docetaxel, and Paclitaxel. These are classified chemically as alkaloid salts (vinblastine series) and taxane esters (docetaxel, paclitaxel). In the broader industry, such raw materials are supplied in grades ranging from research‑grade (≥95 % purity) to GMP‑grade (≥99 % purity) and are often accompanied by a Certificate of Analysis (CoA) confirming assay, impurity profile, and residual solvent limits. Typical specifications include water content below 0.5 % (Karl Fischer), heavy metal limits per USP <232>, and endotoxin levels under 0.5 EU/mL for injectable intermediates.

Industrial‑chemical and laboratory‑chemical categories associated with these compounds usually require compliance with ISO 9001 quality‑management systems and, for pharmaceutical intermediates, Good Manufacturing Practice (GMP) certification. Buyers also look for stability data covering temperature ranges (e.g., - 20 °C to 25 °C) and light‑sensitivity testing, especially for taxanes that degrade under UV exposure. Packaging options in the industry include amber glass vials, sealed HDPE drums, or nitrogen‑purged bulk bags, each selected to maintain moisture and oxygen barriers.

Trade and Export Information - Hubei Honch Pharmaceutical Co., Ltd

China is a major exporter of pharmaceutical intermediates, supplying North America, the European Union, and Southeast Asian markets. Export shipments of anticancer alkaloids and taxanes are typically classified under HS chapter 29 (organic chemicals) and are subject to export licensing and customs documentation such as a Material Safety Data Sheet (MSDS) and a Certificate of Origin. Importing countries often require GMP certification, a full CoA, and sometimes a third‑party analytical verification (e.g., from a certified laboratory) before customs clearance. Common Incoterms for these high‑value, regulated chemicals are FOB Shanghai or CIF Hong Kong, with temperature‑controlled containers or insulated pallets to preserve product integrity during transit.

Regulatory scrutiny is high for cytotoxic agents; many importers request pre‑shipment testing for residual solvents (ICH Q3C) and for stereochemical purity. Packaging must meet UN 3373 (Category B) requirements for transport of dangerous goods, including proper labeling, secondary containment, and documentation of the hazard class. Logistics providers experienced in pharma cold‑chain handling are frequently employed to meet the stringent temperature and security standards of the end market.

Sourcing from Hubei Honch Pharmaceutical Co., Ltd - Buyer Guidance

Prospective buyers should request a current GMP certificate, ISO 9001 certification, and a detailed CoA for each of the five compounds. The CoA should list assay percentage, impurity limits, residual solvent analysis, moisture content, and any applicable pharmacopeial references (USP, EP, JP). Because the supplier’s catalogue does not specify grade, buyers are advised to confirm whether the material is research‑grade or GMP‑grade before placing an order.

Sample procurement is common for these high‑value intermediates; a typical sample size is 10‑20 g, packaged in a sealed amber vial with a desiccant. Verify that the sample includes an accompanying analytical report and that the shipment complies with UN 3373 packaging. Lead times for bulk production of taxanes and vinblastine derivatives in China usually range from 30 to 60 days, depending on synthesis scale and required purity level, so early confirmation of specifications can reduce schedule risk.

What documentation is required before purchasing Vinorelbine tartrate?

Buyers should obtain a current GMP certificate, ISO 9001 certification, and a Certificate of Analysis that details assay, impurity profile, residual solvents, and moisture content for Vinorelbine tartrate.

Can I receive a sample of Docetaxel for laboratory testing?

Yes, a 10‑20 g sample can be requested, packaged in an amber glass vial with desiccant and accompanied by a full CoA and UN 3373 hazardous‑goods documentation.

What purity levels are typical for Paclitaxel supplied from China?

Industry practice offers research‑grade Paclitaxel at ≥95 % purity and GMP‑grade at ≥99 % purity, both verified by HPLC and documented in the CoA.

Which certifications are commonly required for importing Vinblastine sulfate?

Importers usually require the supplier’s GMP certificate, ISO 9001, a CoA, and compliance with pharmacopeial standards such as USP <621> for alkaloid salts.

What packaging options are available for bulk shipments of taxanes?

Bulk shipments are typically packed in nitrogen‑purged HDPE drums or insulated pallets with secondary containment, meeting UN 3373 Category B requirements.

What are the typical lead times for bulk orders of these anticancer agents?

Lead times in China generally range from 30 to 60 days, depending on the required grade, batch size, and any additional analytical testing requested by the buyer.

Which markets most often import these pharmaceutical intermediates?

The United States, European Union members, and Japan are the largest importers of Chinese‑produced anticancer intermediates, followed by Southeast Asian countries.

What Incoterms are usually applied to shipments of these chemicals?

FOB Shanghai and CIF Hong Kong are the most frequently used Incoterms for exporting pharmaceutical raw materials from China, with temperature‑controlled containers when required.